NCT03188536 · FLOW

Participant flow

Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study) · Source last updated 2020-10-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

description
Adult participants with a diagnosis of MM received at least one previous treatment line (standard care of treatment) and experienced symptomatic relapse and/or refractory disease in the previous 6 months, who were followed-up at the time of the study visit. No intervention was administered in this study.
id
FG000
title
Multiple Myeloma (MM) Participants

periods

drop Withdraws
reasons
group Id
FG000
num Subjects
5
type
No relapse/refractoriness(last 6 months)
reasons
group Id
FG000
num Subjects
1
type
Not participated/met inclusion criteria
milestones
achievements
group Id
FG000
num Subjects
282
type
STARTED
achievements
group Id
FG000
num Subjects
276
type
COMPLETED
achievements
group Id
FG000
num Subjects
6
type
NOT COMPLETED
title
Overall Study

pre Assignment Details

Participants with a diagnosis of multiple myeloma with symptomatic relapse and/or refractory disease were observed to collect the retrospective data on Day 1.

recruitment Details

Participants took part in the study at 30 investigative sites in Spain from 26 July 2017 to 30 January 2019.

Complete source fields